| Adverse events: 16. Extrapyramidal adverse events (skewed data) | ||||
|---|---|---|---|---|
| Study | Interventions | Mean score | SD | N |
| Dose 1998 | Valproate ‐ (mean EPS) ‐ high = poor | 3.4 | 1.0 | 14 |
| Dose 1998 | Placebo ‐ (mean EPS) ‐ high = poor | 2.4 | 1.7 | 15 |
| Fisk 1987 | Valproate ‐ (mean tardive dyskinesia score) ‐ high = poor | 4.4 | 0.75 | 22 |
| Fisk 1987 | Placebo ‐ (mean tardive dyskinesia score) ‐ high = poor | 3.5 | 0.7 | 25 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.